510(k) K254033
K254033 is an FDA 510(k) premarket notification submitted by Ceribell, Inc. for the device "Ceribell Instant EEG Headset". The FDA issued a decision of Substantially Equivalent on February 9, 2026. The device falls under product code GXY (Electrode, Cutaneous), a Class II device regulated under 21 CFR 882.1320. Ceribell, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 9, 2026
- Date Received
- December 16, 2025
- Clearance Type
- Abbreviated
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Electrode, Cutaneous
- Device Class
- Class II
- Regulation Number
- 882.1320
- Review Panel
- NE
- Submission Type